leisure time -WSS

leisure time

author：focus 2025-10-01 12:34:46 - browse：27642

Adam's take main illustration — Molly Ferguson/STAT

The approval Friday of Bluebird Bio’s gene therapy for sickle cell disease should have been a momentum-swinging achievement for the long-struggling biotech. Instead, the company mispriced its new drug and fumbled a pivotal financial lifeline.

The consequences of these strategic blunders — arguably, self-inflicted — could imperil Bluebird’s independence, perhaps even its survival.

Bluebird priced Lyfgenia at $3.1 million, while Vertex Pharmaceutical set the cost of Casgevy, its competing sickle cell treatment also approved on Friday, at $2.2 million. Not only is Lyfgenia significantly more expensive, but its prescribing label carries a “black box” safety warning, which requires patients undergo regular blood monitoring for cancer risk. Casgevy has no similar monitoring requirement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： The strange history of BMI, the body mass index

hotspot

WSS

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

A rare thyroid diagnosis led to unexpected, all

Advances in CAR

Medical experts exlpore how to eliminate bias in clinical algorithms

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

UnitedHealth wins $3.3 billion takeover of Amedisys

focus

leisure time

explore

In Memoriam: Notable people who died in 2023

'Make People Better': The CRISPR babies story you probably don't know

Trump demands the U.S. pay no more for drugs than other countries … again

Tuskegee Airman Raymond Cassagnol dies at 102

Dobbs anniversary: the lost opportunity of abortion as health care

Covid hospitalizations on the rise, Humana says

Virginia high school admissions case could be legal follow

How to fix cancer clinical trials' diversity problem

State Dept. review finds Biden bears some blame for Afghanistan failures

The simple reason for the increase in autism diagnosis

knowledge

Thousands protest in Iraq for a second day over burning of Quran in Sweden

ADA: All diabetes patients should be screened for liver condition

Crinetics acromegaly drug succeeds in late

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

GOP inquiry over gain

Ukrainian soldiers say they owe lives to US

focus

hotspot

leisure time

hotspot